NCT01099709View on ClinicalTrials.gov

A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2007

Study Completion Date

August 31, 2007

Conditions
Healthy Volunteers
Interventions
DRUG

Reformulated OXY (oxycodone HCl)

Reformulated OXY 10-mg tablet x 1 dose taken with food.

DRUG

Original OxyContin® (OXY) (oxycodone HCl)

Original OxyContin® (OXY) 10-mg tablet x 1 dose taken with food.

Trial Locations (1)

96813

Covance Clinical Research Unit, Honolulu

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT01099709 - A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets | Biotech Hunter | Biotech Hunter